Bart J. Biemond

Internist-hematologist, Professor
Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands
Amsterdam, Noord-Holland, Netherlands

Presentation(s):

• OC 32.3 - Low-molecular-weight heparin for the prevention of venous thromboembolism in adults with newly diagnosed acute lymphoblastic leukemia; prospective side-study of the HOVON-100 trial

  Monday, June 24, 2024
  10:00 – 10:15 ICT

• PB1428 - Incidence and predictors of venous thromboembolism in patients with acute lymphoblastic leukemia

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT